Stay updated on Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial

Sign up to get notified when there's something new on the Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no changes to study data or visible content.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:37.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The record history now shows an added Revision: v3.4.2 and the removal of the older funding-status notice (Revision: v3.4.1).
    Difference
    0.7%
    Check dated 2026-02-11T02:13:57.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A site-wide funding-lapse notice was added and the release version updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.7%
    Check dated 2026-02-03T23:48:50.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include a new 'Show glossary' option and color-coded change indicators (green for additions and red for deletions). The revision label was updated to v3.4.0 and 'No FEAR Act data' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-27T23:54:06.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-14T00:56:00.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:28:31.000Z thumbnail image

Stay in the know with updates to Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin Combo for B-cell ALL Clinical Trial page.